Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Indoor hydroponic gardening can improve mental health and quality of life for cancer patients

2.

The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

3.

New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.

4.

Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation

5.

CAR T cells improve patients' quality of life: a study


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot